Semios raises $ 100 million in capital to expand agtech platform globally
New financing will drive international expansion as company considers new partnerships and acquisitions
VANCOUVER, BC, September 29, 2021 / PRNewswire / – Semios, a leading precision agriculture platform and one of the world’s largest independent providers of agrotechnology solutions, today announced that it has raised $ 100 million in funding led by Morning Group, a Boston– a private equity and venture capital company committed to investing in socially responsible companies. This funding will enable the agricultural technology provider to accelerate its R&D and deployment of solutions to help producers around the world reduce chemical inputs, better manage water, organize agricultural data and improve crop results. .
“Semios is on a mission to simplify the grower experience, leveraging big data analytics and machine learning to help them mitigate crop risks so they can focus on growing more. of food, in a more sustainable way, ”said Dr. Michel gilbert, CEO of Semios. “We have seen firsthand the challenges our customers face on the ground – from severe droughts and devastating fires to frost, to reduced profitability and increasing regulatory burden. But in the face of these challenges, farmers are adapting to meet nutritional needs. needs of our growing population with new technologies. Our recent acquisitions aim to bring together the tools farmers need to manage their crops under one roof. This latest round of funding will help us continue to support the agriculture industry as it faces some of its most difficult challenges yet. “
To date, Semios has raised more than $ 225 million in external capital. Last year, Semios announced $ 100 million in financing, also led by Morningside Group, which strengthened the company’s balance sheet for the acquisitions of Altrac, Centricity and Agworld in 2021. Integrating third-party farming solutions into its crop management platform helps growers get the most accurate view of their crop’s development as it happens, all in one location, which leads to better decision making and ultimately better growing results in a more unstable climate and harsh growing conditions.
“Morningside invests in companies committed to tackling pressing global challenges head-on,” said Mick sawka, investment manager at Morningside Group. “The ability to not only maintain but also improve the sustainability of our food systems amid the complex dynamics of climate change is one of the most pressing global needs of our time. Semios is a leader in helping farmers meet this challenge and we “I am proud to be by their side.”
With over 120 million acres of row and permanent crops under management today, Semios serves growers, agronomists and agricultural retailers across the United States, Canada, Australia, New Zealand, Europe and South Africa with solutions as diverse as farm management planning, logistics and execution, record keeping, agronomy and automation.
UBS Investment Bank acted as the exclusive placement agent for Semios.
About Semios Founded in 2010, Vancouver– Semios based offers Precision Agriculture as a Service™ which started with real-time harvest data and pest control tools for growers of tree fruits, nuts and other permanent crops. Leverage a network of sensors that provide more than 500M Data points measuring daily climate, soil moisture, insect and disease activity, we apply big data analytics and machine learning to reduce and mitigate crop risks for growers. Semios has been named in the Global Cleantech 100, an annual list of the world’s 100 most innovative cleantech companies, and in the Thrive Top 50, the list of the world’s top 50 AgTech companies. In 2021, Semios acquired Altrac, Centricity and Agworld to form one of the largest independent providers of AgTech solutions in the world.
Learn more about Semios at www.semios.com.
About Morningside Venture Investments: Morningside is a diversified investment group founded in 1986 and engaged in private equity and venture capital investments. Morningside is an active investor in early stage life science companies formed around new technologies that represent a high degree of novelty to existing technologies.
More information is available at www.morningside.com.